Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
-
* Corresponding author: Alan G Wade alangwade@fastmail.fm
BMC Medicine 2010, 8:51 doi:10.1186/1741-7015-8-51
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 09 Mar 2010 | |
| Reviewer's Report | Geert Mayer | 26 Mar 2010 | |
| Reviewer's Report | Teresa Paiva | 29 Mar 2010 | |
| Reviewer's Report | Ulrich Voderholzer | 06 May 2010 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 24 May 2010 |
| Reviewer's Report | Geert Mayer | 31 May 2010 | |
| Reviewer's Report | Ulrich Voderholzer | 18 Jun 2010 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 29 Jun 2010 |
| Resubmission - Version 4 | Manuscript | Author's comment | 30 Jun 2010 |
| Reviewer's Report | Geert Mayer | 19 Jul 2010 | |
| Editorial acceptance | 21 Jul 2010 | ||
| Published | 16 Aug 2010 |